Cargando…

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

CD28 and CTLA-4 (CD152) play essential roles in regulating T cell immunity, balancing the activation and inhibition of T cell responses, respectively. Although both receptors share the same ligands, CD80 and CD86, the specific requirement for two distinct ligands remains obscure. In the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kennedy, Alan, Waters, Erin, Rowshanravan, Behzad, Hinze, Claudia, Williams, Cayman, Janman, Daniel, Fox, Thomas A., Booth, Claire, Pesenacker, Anne M., Halliday, Neil, Soskic, Blagoje, Kaur, Satdip, Qureshi, Omar S., Morris, Emma C., Ikemizu, Shinji, Paluch, Christopher, Huo, Jiandong, Davis, Simon J., Boucrot, Emmanuel, Walker, Lucy S. K., Sansom, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477731/ https://www.ncbi.nlm.nih.gov/pubmed/35999394 http://dx.doi.org/10.1038/s41590-022-01289-w

Ejemplares similares

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
por: Halliday, Neil, et al.
Publicado: (2020)

The CTLA‐4 immune checkpoint protein regulates PD‐L1:PD‐1 interaction via transendocytosis of its ligand CD80
por: Kennedy, Alan, et al.
Publicado: (2023)

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
por: Soskic, Blagoje, et al.
Publicado: (2021)

Regulation of CTLA‐4 recycling by LRBA and Rab11
por: Janman, Daniel, et al.
Publicado: (2021)

Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
por: Williams, Cayman, et al.
Publicado: (2022)

Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
por: Pinto, Bruna F., et al.
Publicado: (2022)

Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?
por: Ville, Simon, et al.
Publicado: (2015)

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis
por: Marquez Pete, Noelia, et al.
Publicado: (2020)

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies
por: Lin, Shouheng, et al.
Publicado: (2021)

The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
por: Liu, Weixi, et al.
Publicado: (2021)

Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation
por: Glinos, Dafni A., et al.
Publicado: (2020)

Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish
por: Lu, Tao-Zhen, et al.
Publicado: (2022)

By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1
por: Kleinpeter, Patricia, et al.
Publicado: (2019)

Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival
por: Tian, Min, et al.
Publicado: (2013)

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
por: Sato, Takashi, et al.
Publicado: (2022)

Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma
por: Chang, Cheng-Shyong, et al.
Publicado: (2007)

Differential Role for CD80 and CD86 in the Regulation of the Innate Immune Response in Murine Polymicrobial Sepsis
por: Nolan, Anna, et al.
Publicado: (2009)

In Vivo Imaging of Local Inflammation: Monitoring LPS-Induced CD80/CD86 Upregulation by PET
por: Taddio, Marco F., et al.
Publicado: (2020)

Immune suppression in cynomolgus monkeys by XPro9523: An improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn
por: Bernett, Matthew J., et al.
Publicado: (2013)

Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists
por: Poirier, Nicolas, et al.
Publicado: (2012)

Preclinical imaging of the co-stimulatory molecules CD80 and CD86 with indium-111-labeled belatacept in atherosclerosis
por: Meletta, Romana, et al.
Publicado: (2016)

Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis
por: HUANG, YANLAN, et al.
Publicado: (2020)

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
por: Ikeda, Hideki, et al.
Publicado: (2023)

Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68(+) Cells during Chronic HBV Infection
por: Said, Elias A., et al.
Publicado: (2016)

Ciprofloxacin promotes polarization of CD86(+)CD206(−) macrophages to suppress liver cancer
por: Fan, Mengtian, et al.
Publicado: (2020)

CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-Cells
por: Lim, Tong Seng, et al.
Publicado: (2012)

Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
por: Trzupek, Dominik, et al.
Publicado: (2020)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
por: Liu, Po-Chun, et al.
Publicado: (2020)

CD86(+)/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
por: Sun, Dalong, et al.
Publicado: (2020)

Diabetes-Mediated Toxicity Resulted in the Expression of CD80 and CD86 on Neutrophils after Delayed Wound Healing in Male Rats
por: Ebaid, Hossam, et al.
Publicado: (2020)

Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras
por: Park, Ga Bin, et al.
Publicado: (2011)

Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals
por: Liaskou, Evaggelia, et al.
Publicado: (2017)

Zn(1.86)Cd(0.14)(OH)VO(4)
por: Đorđević, Tamara, et al.
Publicado: (2010)

Talaromyces marneffei Can Capture CD86 Proteins of Macrophages in vitro
por: Fang, Jinling, et al.
Publicado: (2022)

Expression of Peripheral Blood DCs CD86, CD80, and Th1/Th2 in Sepsis Patients and Their Value on Survival Prediction
por: Du, Ke, et al.
Publicado: (2022)

Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4(+) T Cells Independent of the PD-1 Receptor
por: Shin, Tahiro, et al.
Publicado: (2003)

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
por: Julià, Antonio, et al.
Publicado: (2021)

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023)

Dominant Role of CD80–CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells
por: Chevrier, Stéphane, et al.
Publicado: (2012)

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?
por: Grywalska, Ewelina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7bmnns577vsvgcb4f4m4nvmao